Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
disease prevention
Biotech
'Why We Vaccinate': BIO targets lawmakers for immunization push
As disinformation skyrockets, BIO is hoping to set the record straight, rolling out a campaign highlighting the value of vaccines.
Gabrielle Masson
Oct 20, 2025 1:50pm
Fierce Pharma
Cidara snares BARDA award to boost R&D, production of flu asset
Oct 3, 2025 10:10am
Corsera launches with $50M for predictive AI tool, RNAi asset
Sep 2, 2025 6:30am
AstraZeneca shows durability of its COVID-preventing antibodies
Nov 18, 2021 6:28am
AstraZeneca closes in on EUA filing for COVID-19 antibody
Sep 30, 2021 9:00am
AstraZeneca COVID-19 antibody fails in post-exposure prevention
Jun 15, 2021 7:55am
